You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Urethral Neoplasms

Showing 1 - 25 of 1,781
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urologic Cancer, Urologic Tumors, Bladder Cancer Trial in Boston (Electromagnetic Guided Laparoscopy, Ultrasound)

Not yet recruiting
  • Urologic Cancer
  • +7 more
  • Electromagnetic Guided Laparoscopy
  • Ultrasound
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2023

Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Copper-64 labeled Granzyme B (64Cu-GRIP B)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Jun 7, 2023

Primary and Metastatic Tumors in Renal Cell Carcinoma and

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Immune checkpoint inhibitor targeting PD1
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jan 27, 2023

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Prostate Cancer Trial in Philadelphia (Daily adaptive SBRT with urethral sparing)

Not yet recruiting
  • Prostate Cancer
  • Daily adaptive SBRT with urethral sparing
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 26, 2023

Prostate Cancer Trial in Candiolo (Robotic hemi-prostatectomy with urethral preservation)

Recruiting
  • Prostate Cancer
  • Robotic hemi-prostatectomy with urethral preservation
  • Candiolo, TO, Italy
    Fondazione del Piemonte per l'Oncologia
Apr 16, 2023

Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)

Active, not recruiting
  • Melanoma
  • +9 more
  • MRx0518 Capsules
  • MRx0518/placebo Capsules
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Aug 10, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +13 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 8, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

Active, not recruiting
  • Hydronephrosis
  • +18 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Urothelial Carcinoma, Urethral Tumors, Urinary Bladder Tumors Trial run by the NCI (Cabozantinib)

Active, not recruiting
Has Results
  • Urothelial Carcinoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +18 more
  • Los Angeles, California
  • +2 more
Jun 28, 2022

Localized Prostate Carcinoma Trial in Milan (prostate SBRT)

Not yet recruiting
  • Localized Prostate Carcinoma
  • prostate SBRT
  • Milan, MI, Italy
    San Raffaele Scientific Institute
Jun 29, 2023

Prostate Cancer Trial in Birmingham (16 French Foley Catheter)

Recruiting
  • Prostate Cancer
  • 16 French Foley Catheter
  • Birmingham, Alabama
    Hazelrig-Salter Radiation Oncology Center
Aug 20, 2022

Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

Completed
  • Urinary Bladder Cancer
  • +4 more
  • Neutrophil to lymphocyte ratio
  • Cairo, Egypt
    Ain Shams university
Jul 15, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,

Recruiting
  • Distal Urethral Cancer
  • +8 more
  • afatinib dimaleate
  • laboratory biomarker analysis
  • Atlanta, Georgia
  • +5 more
Sep 24, 2021

Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,

Not yet recruiting
  • Bladder Squamous Cell Carcinoma
  • +10 more
  • Biospecimen Collection
  • +5 more
  • Atlanta, Georgia
  • +3 more
Feb 20, 2023

Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

Recruiting
  • Advanced Bladder Urothelial Carcinoma
  • +23 more
  • Riverside, California
  • +8 more
Jul 16, 2022

Prostate Cancer, Urinary Incontinence Trial in Shanghai (SFUR-RARP, Standard RARP)

Completed
  • Prostate Cancer
  • Urinary Incontinence
  • SFUR-RARP
  • Standard RARP
  • Shanghai, Shanghai, China
    Changhai Hospital
May 11, 2022

Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral

Recruiting
  • Locally Advanced Renal Pelvis Urothelial Carcinoma
  • +20 more
  • Duarte, California
  • +16 more
Aug 10, 2022

Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • +2 more
  • PDD-TURBT with hexaminolevulinate (Hexvix®)
  • Power Led Saphira (TM) from KARL STORZ
  • (no location specified)
Jul 24, 2023

Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

Active, not recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +35 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +7 more
Jan 3, 2023

Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)

Active, not recruiting
  • Urothelial Carcinoma
  • +3 more
  • Biospecimen Collection
  • Los Angeles, California
  • +7 more
Feb 14, 2022

Non-muscle Invasive Bladder Cancer (NMIBC) Trial in Rozzano (Hyaluronic Acid (HA) sodium salt and Hydeal-D)

Terminated
  • Non-muscle Invasive Bladder Cancer (NMIBC)
  • Hyaluronic Acid (HA) sodium salt and Hydeal-D
  • Rozzano, Mi, Italy
    Humanitas Research Hospital
Sep 29, 2023